These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 816747)

  • 21. Detection of antibodies against the glycolipid fraction of Trypanosoma cruzi in infected mice.
    Kaneda Y; Tachibana H; Goutsu T
    J Parasitol; 1987 Jun; 73(3):658-61. PubMed ID: 3110395
    [No Abstract]   [Full Text] [Related]  

  • 22. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
    Wallace A; Sanchez G; Venegas J; Solari A
    Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease.
    Kierszenbaum F; Lopez HM; Sztein MB
    Immunology; 1994 Mar; 81(3):462-7. PubMed ID: 8206517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypanosoma cruzi and human ubiquitin are immunologically distinct proteins despite only three amino acid difference in their primary sequence.
    Télles S; Abate T; Slezynger TC; Henríquez DA
    FEMS Immunol Med Microbiol; 1999 Jun; 24(2):123-30. PubMed ID: 10378411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice.
    Tzelepis F; de Alencar BC; Penido ML; Gazzinelli RT; Persechini PM; Rodrigues MM
    Infect Immun; 2006 Apr; 74(4):2477-81. PubMed ID: 16552083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-dependent cytolysis of Trypanosoma cruzi by human polymorphonuclear leukocytes.
    Olabuenaga SE; Cardoni RL; Segura EL; Riera NE; de Bracco MM
    Cell Immunol; 1979 Jun; 45(1):85-93. PubMed ID: 110466
    [No Abstract]   [Full Text] [Related]  

  • 27. Challenge of Trypanosoma cruzi chronically infected mice with trypomastigotes activates the immune system and reduces subpatent parasitemia levels.
    Marinho CR; Bastos KR; Sardinha LR; Grisotto MG; Lima MR; Alvarez JM
    J Parasitol; 2004 Jun; 90(3):516-23. PubMed ID: 15270095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trypanosoma cruzi: the T-cell dependence of the primary immune response and the effects of depletion of T cells and Ig-bearing cells on immunological memory.
    Burgess DE; Hanson WL
    Cell Immunol; 1980 Jun; 52(1):176-86. PubMed ID: 6771021
    [No Abstract]   [Full Text] [Related]  

  • 29. Direct agglutination test in the detection of anti-Trypanosoma cruzi antibodies in mice.
    Schmunis GA; Szarfman A; Vattuone N
    J Parasitol; 1972 Oct; 58(5):1006-7. PubMed ID: 4627886
    [No Abstract]   [Full Text] [Related]  

  • 30. Trypanosoma cruzi antibodies in mice infected with different strains of T.cruzi.
    Peralta JM; Filardi L; Loures MA; Torres ST
    J Parasitol; 1980 Apr; 66(2):342-4. PubMed ID: 6771373
    [No Abstract]   [Full Text] [Related]  

  • 31. Restoration of in vitro immune responses of spleen cells from mice infected with Trypanosoma cruzi by supernatants containing interleukin 2.
    Tarleton RL; Kuhn RE
    J Immunol; 1984 Sep; 133(3):1570-5. PubMed ID: 6431001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immune response in Trypanosoma cruzi infection].
    Rottenberg ME; de Titto EH; Cardoni RL; Segura EL
    Rev Argent Microbiol; 1991; 23(2):101-21. PubMed ID: 1815267
    [No Abstract]   [Full Text] [Related]  

  • 33. The protective effect of non-immunologic granulomatous inflammation in Trypanosoma cruzi infection of mice.
    De Mesquita RP
    Rev Bras Biol; 1979 Mar; 39(1):99-102. PubMed ID: 111311
    [No Abstract]   [Full Text] [Related]  

  • 34. Protective immunisation of mice using cell surface glycoprotein from Trypanosoma cruzi.
    Scott MT; Snary D
    Nature; 1979 Nov; 282(5734):73-4. PubMed ID: 116128
    [No Abstract]   [Full Text] [Related]  

  • 35. Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi.
    Zuñiga C; Palau T; Penin P; Gamallo C; de Diego JA
    Trop Med Int Health; 1997 May; 2(5):482-7. PubMed ID: 9217704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?
    Basso B; Marini V
    Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Circulating antigens of Trypanosoma cruzi in patients with Chagas' disease in an endemic area].
    Alonso JM; Pividori S; Guilleron C
    Medicina (B Aires); 1986; 46(1):69-72. PubMed ID: 3100908
    [No Abstract]   [Full Text] [Related]  

  • 38. Partial characterization of a Trypanosoma cruzi-released decomplementing factor.
    Cunningham DS; Brewer TE; Kuhn RE; Craig WH
    J Parasitol; 1981 Aug; 67(4):475-80. PubMed ID: 6790694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen-specific T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi infection.
    Martin DL; Tarleton RL
    J Immunol; 2005 Feb; 174(3):1594-601. PubMed ID: 15661921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coincidence of tissue antibody and cardiac pathology in mice infected with Trypanosoma cruzi.
    Lozykowski MG; McCormick TS; Rowland EC
    Trans R Soc Trop Med Hyg; 1991; 85(2):225-6. PubMed ID: 1909470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.